MedPath

Palmitic Acid in the Sn-2 Position of Triacylglycerols and Postprandial Lipemia

Not Applicable
Completed
Conditions
Healthy Men
Raised Fasting Plasma Triacylglycerol Concentrations
Interventions
Dietary Supplement: High-fat meal containing native palm olein
Dietary Supplement: High-fat meal containing interesterified palm olein
Registration Number
NCT01710280
Lead Sponsor
King's College London
Brief Summary

The purpose of this study is to determine whether high-fat meals rich in palmitic acid in the sn-2 position decrease lipaemia in men aged 40-70 y with higher than optimal fasting triacylglycerol concentrations.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
11
Inclusion Criteria
  • Healthy males
  • Non-smokers
  • Aged 40-70 years
  • Fasting TAG concentrations ≥1.5 mmol/L.
Exclusion Criteria
  • Reported history of CVD (myocardial infarction, angina, venous thrombosis, stroke), impaired fasting glucose/uncontrolled type 2 diabetes (or fasting glucose ≥ 6.1 mmol/L), cancer, kidney, liver or bowel disease.
  • Presence of gastrointestinal disorder or use of drug, which is likely to alter gastrointestinal motility or nutrient absorption.
  • History of substance abuse or alcoholism (previous weekly alcohol intake >60 units/men)
  • Current self-reported weekly alcohol intake exceeding 28 units
  • Allergy or intolerance to any component of test meals
  • Unwilling to restrict consumption of any source of fish oil for the length of the study
  • Weight change of >3kg in preceding 2 months
  • Body Mass Index <20 and >35 kg/m2
  • Fasting blood cholesterol > 7.8 mmol/L
  • Current cigarette smoker.
  • Current use of lipid lowering medication

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Native palm oleinHigh-fat meal containing native palm olein75 g native palm olein
Interesterified palm oleinHigh-fat meal containing interesterified palm olein75 g interesterified palm olein
Primary Outcome Measures
NameTimeMethod
Incremental AUC (change from baseline in overall response) for plasma triacylglycerol concentrations1-6 h post-meal
Secondary Outcome Measures
NameTimeMethod
Incremental AUC for plasma non-esterified fatty acid concentrations1-6 h post-meal
Changes from baseline in digital volume pulse2,4,5,6 h post-meal
Changes from baseline in blood pressure2,4,5,6 h post-meal

Trial Locations

Locations (1)

Diabetes & Nutritional Sciences Division, King's College London.

🇬🇧

London, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath